SAB Biotherapeutics, Inc.SABS
Close of Friday, October 23, 2026 · SAB Biotherapeutics, Inc. is trading below its Pivot, OnlyAlpha's long-term trend line.
Price
$2.84
vs its Pivot
-23.2%
OnlyAlpha Score
43
Trend
Below its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| -15.2% | -24.1% | -5.3% | — | — |
No dividend in the last 12 months.
Who runs and owns it
In these funds
Big investors that own it (latest 13F)
| Perceptive Advisors | 0.4% of holdings |
| RA Capital | 0.1% of holdings |
Get SABS in your free daily emailAfter every close: whether SABS is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track SABS free → Full Stock check
Track SABS free → Full Stock check